Resalis Therapeutics Announces Initiation of Phase 1 Clinical Trial for RES-010 in Obesity

Dec 03, 2024

Resalis Therapeutics Announces Initiation of Phase 1 Clinical Trial for RES-010 in Obesity

View PDF